CASI Pharmaceuticals (CASI) Institutional Ownership $2.43 +0.07 (+2.92%) As of 01:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for CASI Pharmaceuticals (NASDAQ:CASI)CurrentInstitutional OwnershipPercentage22.23%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$4.10MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$729.06K Get CASI Insider Trade Alerts Want to know when executives and insiders are buying or selling CASI Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CASI Institutional Buying and Selling by Quarter CASI Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/12/2025 Foresite Capital Management VI LLC787,121$929K0.5%-40.8%6.399% 5/16/2025 Woodline Partners LP164,365$355K0.0%+64.9%1.336% 2/17/2025 Woodline Partners LP99,690$282K0.0%+226.5%0.644% 2/14/2025 Foresite Capital Management VI LLC1,329,383$3.76M1.7%N/A8.582% 2/13/2025 ADAR1 Capital Management LLC46,320$131K0.0%-28.6%0.299% 2/10/2025 Wellington Shields & Co. LLC30,091$85K0.0%-30.2%0.194% 8/9/2024 Renaissance Technologies LLC40,800$224K0.0%+10.9%0.304% 8/5/2024 Wellington Shields Capital Management LLC89,217$491K0.1%-3.3%0.666% 5/4/2024 Howland Capital Management LLC40,429$146K0.0%N/A0.302% 5/3/2024 Wellington Shields Capital Management LLC92,217$333K0.1%-30.7%0.688% Get the Latest News and Ratings for CASI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CASI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023 Wellington Shields Capital Management LLC180,143$418K0.1%N/A1.352% 5/11/2023 Wellington Shields & Co. LLC139,315$323K0.1%N/A1.046% 11/4/2022 Prudential Financial Inc.11,000$29K0.0%N/A0.081% 9/16/2022 Federated Hermes Inc.1,015,000$2.90M0.0%-90.0%7.460% 8/15/2022 Wellington Shields Capital Management LLC213,250$610K0.1%-90.0%1.567% 8/12/2022 Ikarian Capital LLC132,014$378K0.1%-90.0%0.970% 8/12/2022 Wellington Shields & Co. LLC145,317$416K0.1%-90.0%1.068% 7/27/2022 Bailard Inc.31,530$90K0.0%+25.6%0.232% 5/12/2022 Wellington Shields Capital Management LLC2,132,547$1.73M0.2%-2.6%1.561% 5/9/2022 Wellington Shields & Co. LLC1,453,190$1.18M0.4%+27.3%1.064% 2/16/2022 Wellington Shields & Co. LLC1,141,190$913K0.2%-37.7%0.816% 2/15/2022 Wellington Shields Capital Management LLC2,188,547$1.75M0.2%-3.1%1.566% 11/15/2021 Marshall Wace LLP952,037$1.13M0.0%+325.6%0.681% 11/12/2021 Renaissance Technologies LLC1,618,155$1.93M0.0%+4.6%1.158% 11/12/2021 Geode Capital Management LLC944,729$1.12M0.0%+34.2%0.676% 11/12/2021 Connor Clark & Lunn Investment Management Ltd.60,904$72K0.0%N/A0.044% 11/10/2021 Goldman Sachs Group Inc.199,986$238K0.0%+32.3%0.143% 11/9/2021BlackRock Inc.1,165,942$1.39M0.0%-1.3%0.834% 8/26/2021 Y Intercept Hong Kong Ltd16,246$25K0.0%N/A0.012% 8/25/2021 Marshall Wace LLP223,709$347K0.0%N/A0.160% 8/17/2021 Millennium Management LLC1,112,208$1.72M0.0%+1,211.7%0.796% 8/17/2021 Price T Rowe Associates Inc. MD105,200$163K0.0%-32.3%0.075% 8/17/2021 Prudential Financial Inc.16,600$26K0.0%N/A0.012% 8/17/2021 Boothbay Fund Management LLC185,988$288K0.0%+14.8%0.133% 8/16/2021 Squarepoint Ops LLC22,698$35K0.0%+107.4%0.016% 8/16/2021 LMR Partners LLP30,360$47K0.0%N/A0.022% 8/16/2021 Schonfeld Strategic Advisors LLC20,600$32K0.0%N/A0.015% 8/16/2021 Charles Schwab Investment Management Inc.405,290$629K0.0%-20.0%0.290% 8/16/2021 State Street Corp194,842$302K0.0%-81.3%0.139% 8/16/2021Tibra Equities Europe Ltd216,300$335K0.1%N/A0.155% Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow8/16/2021 Goldman Sachs Group Inc.151,183$234K0.0%+143.6%0.108% 8/16/2021 Marshall Wace LLP223,709$347K0.0%N/A0.160% 8/16/2021 Wellington Shields Capital Management LLC2,258,264$3.50M0.4%+1.2%1.615% 8/13/2021 Renaissance Technologies LLC1,546,306$2.40M0.0%+504.7%1.106% 8/13/2021 Northern Trust Corp243,200$377K0.0%-70.4%0.174% 8/13/2021 Geode Capital Management LLC703,888$1.09M0.0%-35.6%0.504% 8/13/2021 Vanguard Group Inc.3,904,627$6.05M0.0%-7.6%2.793% 8/13/2021 Bailard Inc.40,400$63K0.0%N/A0.029% 8/12/2021 Dimensional Fund Advisors LP274,344$425K0.0%+4.6%0.196% 8/12/2021 JPMorgan Chase & Co.191,523$296K0.0%+8.7%0.137% 8/12/2021Ergoteles LLC300,400$466K0.0%N/A0.215% 8/11/2021 Bank of New York Mellon Corp36,436$56K0.0%-80.6%0.026% 8/11/2021BlackRock Inc.1,181,599$1.83M0.0%-70.5%0.845% 8/5/2021 GSA Capital Partners LLP78,572$122K0.0%+377.9%0.056% 5/18/2021 Millennium Management LLC84,791$203K0.0%-34.3%0.061% (Data available from 1/1/2016 forward) CASI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CASI shares? During the previous two years, the following institutional investors and hedge funds held shares of CASI Pharmaceuticals shares: Foresite Capital Management VI LLC ($929K), Wellington Shields Capital Management LLC ($491K), Woodline Partners LP ($355K), Renaissance Technologies LLC ($224K), Howland Capital Management LLC ($146K), and ADAR1 Capital Management LLC ($131K), and Wellington Shields & Co. LLC ($85K).Learn more on CASI Pharmaceuticals' institutional investors. What percentage of CASI Pharmaceuticals' stock is owned by institutional investors? 22.23% of CASI Pharmaceuticals' stock is owned by institutional investors. Learn more on CASI's institutional investor holdings. Which institutional investors have been buying CASI Pharmaceuticals' stock? The following institutional investors have purchased CASI Pharmaceuticals' stock in the last 24 months: Foresite Capital Management VI LLC ($1.33M), Woodline Partners LP ($133.83K), Howland Capital Management LLC ($40.43K), and Renaissance Technologies LLC ($4K). How much institutional buying is happening at CASI Pharmaceuticals? Institutional investors have bought a total of 1,463,216 shares in the last 24 months. This purchase volume represents approximately $4.10M in transactions. Which of CASI Pharmaceuticals' major shareholders have been selling company stock? The following institutional investors have sold CASI Pharmaceuticals stock in the last 24 months: Foresite Capital Management VI LLC ($542.26K), ADAR1 Capital Management LLC ($18.52K), and Wellington Shields & Co. LLC ($13K). How much institutional selling is happening at CASI Pharmaceuticals? Institutional investors have sold a total of 573,777 shares in the last 24 months. This volume of shares sold represents approximately $729.06K in transactions. Related Companies Protara Therapeutics Institutional Ownership Zentalis Pharmaceuticals Institutional Ownership Connect Biopharma Institutional Ownership Zura Bio Institutional Ownership Corbus Pharmaceuticals Institutional Ownership Cognition Therapeutics Institutional Ownership Cassava Sciences Institutional Ownership Cardiol Therapeutics Institutional Ownership Skye Bioscience Institutional Ownership Spero Therapeutics Institutional Ownership This page (NASDAQ:CASI) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CASI Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CASI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access